PPARD and colonic neoplasm: More recent studies by Liou et al. provide evidence that 14-3-3ɘ, a downstream target of PPARδ, is responsible for its anti-apoptotic effects, and is effectively downregulated by sulindac sulfide, sulfone, and indomethacin treatment in colon cancer cells (93).